Aspiriant LLC’s Honeywell HON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$765K Buy
3,385
+1,904
+129% +$435K 0.02% 177
2025
Q4
$289K Buy
1,481
+18
+1% +$3.52K 0.01% 284
2025
Q3
$290K Sell
1,463
-383
-21% -$80K 0.01% 255
2025
Q2
$405K Sell
1,846
-379
-17% -$76.7K 0.01% 222
2025
Q1
$444K Sell
2,225
-438
-16% -$88.6K 0.02% 197
2024
Q4
$567K Buy
2,663
+416
+19% +$86.8K 0.02% 180
2024
Q3
$438K Buy
2,247
+737
+49% +$143K 0.02% 197
2024
Q2
$304K Sell
1,510
-1,102
-42% -$210K 0.01% 226
2024
Q1
$505K Hold
2,612
0.02% 198
2023
Q4
$516K Sell
2,612
-22
-0.8% -$3.97K 0.02% 185
2023
Q3
$459K Buy
2,634
+184
+8% +$33.7K 0.02% 187
2023
Q2
$479K Buy
2,450
+414
+20% +$76.9K 0.02% 181
2023
Q1
$367K Sell
2,036
-68
-3% -$12.8K 0.02% 199
2022
Q4
$425K Buy
2,104
+116
+6% +$22.2K 0.02% 189
2022
Q3
$314K Buy
1,988
+151
+8% +$26.3K 0.02% 207
2022
Q2
$302K Buy
1,837
+313
+21% +$56.2K 0.01% 210
2022
Q1
$280K Sell
1,524
-167
-10% -$30.9K 0.02% 231
2021
Q4
$331K Buy
1,691
+35
+2% +$7.07K 0.02% 223
2021
Q3
$332K Sell
1,656
-384
-19% -$81.9K 0.02% 186
2021
Q2
$422K Buy
2,040
+420
+26% +$88.8K 0.02% 169
2021
Q1
$332K Sell
1,620
-73
-4% -$14.3K 0.02% 171
2020
Q4
$340K Buy
1,693
+80
+5% +$14.5K 0.02% 162
2020
Q3
$250K Sell
1,613
-168
-9% -$25K 0.02% 193
2020
Q2
$243K Sell
1,781
-123
-6% -$16.3K 0.02% 166
2020
Q1
$240K Sell
1,904
-1,233
-39% -$190K 0.02% 168
2019
Q4
$522K Sell
3,137
-197
-6% -$32.2K 0.05% 134
2019
Q3
$532K Sell
3,334
-82
-2% -$13K 0.05% 143
2019
Q2
$562K Sell
3,416
-46
-1% -$7.32K 0.05% 140
2019
Q1
$519K Sell
3,462
-61
-2% -$8.52K 0.04% 144
2018
Q4
$439K Buy
3,523
+97
+3% +$13.2K 0.03% 152
2018
Q3
$514K Sell
3,426
-265
-7% -$37.6K 0.04% 155
2018
Q2
$480K Buy
3,691
+1,734
+89% +$231K 0.04% 161
2018
Q1
$255K Buy
+1,957
New +$271K 0.02% 209
2017
Q4
Sell
-1,904
Closed -$244K 120
2017
Q3
$244K Buy
+1,904
New +$236K 0.02% 181

Other funds holding HON

Aspiriant LLC's HON Position: Q1 2026 in Review

Aspiriant LLC increased its Honeywell (HON) stake by 129% in Q1 2026, buying an estimated $435K and bringing the position to 3,385 shares worth $765K. The position accounts for 0.02% of the portfolio, ranked #177.

Aspiriant LLC first reported a position in HON in Q3 2017 and has held it in 34 quarters since. 2,793 funds tracked by Wall St. Rank hold HON as of Q1 2026.

  • Aspiriant LLC held 3,385 shares of Honeywell worth $765K as of Q1 2026.
  • Aspiriant LLC bought 1,904 Honeywell shares in Q1 2026, an estimated $435K.
  • Honeywell made up 0.02% of Aspiriant LLC's portfolio in Q1 2026, its #177 holding.
  • Aspiriant LLC first reported a position in Honeywell in Q3 2017 and has held it in 34 quarters since.
  • 2,793 funds tracked by Wall St. Rank held Honeywell as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.